REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Explorna Therapeutics Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Rental and Leasing Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | Educational Support Services | All Other Miscellaneous Ambulatory Health Care Services | Administration of Economic Programs
Full name: Explorna Therapeutics Sp. z o.o. Profile Updated: February 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

ExploRNA Therapeutics is a biotech company specializing in the development of mRNA technology and therapies for pharmaceutical partners. The company is focused on making mRNA technology more accessible in low-income countries to help fight diseases. ExploRNA Therapeutics offers licensing of their proprietary capping technology, support for mRNA manufacturing processes, and joint development of therapeutic programs. They have received funding from the Bill & Melinda Gates Foundation and the National Center for Research and Development for their innovative mRNA cap analogs. The company's team members have extensive experience and expertise in the field of nucleotides, nucleic acids, and mRNA technology.

Headquarters
Ul. Zwirki I Wigury 93/2157
Warsaw; Mazowieckie; Postal Code: 02-089

Contact Details: Purchase the Explorna Therapeutics Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Explorna Therapeutics Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Explorna Therapeutics Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Explorna Therapeutics Sp. z o.o. report to view the information.
Incorporation Date:
May 16, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
47.8%
Purchase this report to view the information.
23.08%
Company Performance
Financial values in the chart are available after Explorna Therapeutics Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-43.26%▼
Total operating revenue
-91.19%▼
Operating Profit/Loss (EBIT)
-43.02%▼
EBITDA
-74.52%▼
Net Profit/Loss for the Period
-39.42%▼
Total Assets
-30.66%▼
Total Equity
-30.2%▼
Operating Profit Margin (ROS)
-1677.77%▼
Net Profit Margin
-1528.19%▼
Return on Equity (ROE)
-21.61%▼
Quick Ratio
4.95%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo